Kronos Bio, Inc. (KRON)
NASDAQ: KRON · Real-Time Price · USD
0.874
+0.014 (1.66%)
Nov 21, 2024, 4:00 PM EST - Market closed
Kronos Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 53 | 73 | 92 | 766 | 1,674 | - | |
| Market Cap Growth | -20.21% | -20.92% | -87.96% | -54.25% | - | - | |
| Enterprise Value | -47 | -84 | -134 | 401 | 1,790 | - | |
| Last Close Price | 0.86 | 1.25 | 1.62 | 13.59 | 29.87 | - | |
| PS Ratio | 5.19 | 11.59 | - | - | - | - | |
| PB Ratio | 0.47 | 0.46 | 0.38 | 2.22 | 3.60 | - | |
| P/TBV Ratio | 0.54 | 0.46 | 0.38 | 2.22 | 3.60 | - | |
| Debt / Equity Ratio | 0.23 | 0.18 | 0.13 | 0.10 | 0.07 | 0.01 | |
| Asset Turnover | 0.05 | 0.02 | - | - | - | - | |
| Quick Ratio | 8.12 | 7.01 | 11.09 | 24.98 | 32.18 | 34.25 | |
| Current Ratio | 8.32 | 7.24 | 11.37 | 25.51 | 32.65 | 34.60 | |
| Return on Equity (ROE) | -59.08% | -55.84% | -45.18% | -37.27% | -31.30% | -29.20% | |
| Return on Assets (ROA) | -25.13% | -28.83% | -24.97% | -20.95% | -11.80% | -18.23% | |
| Return on Capital (ROIC) | -28.26% | -31.65% | -26.19% | -21.59% | -12.14% | -18.81% | |
| Earnings Yield | -165.05% | -154.57% | -144.51% | -19.73% | -5.28% | - | |
| FCF Yield | -149.76% | -108.73% | -99.27% | -15.96% | -2.84% | - | |
| Buyback Yield / Dilution | -3.93% | -2.75% | -2.64% | -236.38% | -208.35% | -8.69% | |
| Total Shareholder Return | -3.93% | -2.75% | -2.64% | -236.38% | -208.35% | -8.69% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.